Optiver Holding
FOLD

Optiver Holding’s Amicus Therapeutics FOLD Stock Holding History

Optiver Holding’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Buy
7,707
+731
+10% +$10.5K ﹤0.01% 882
2025
Q4 		$99.3K Buy
6,976
+5,174
+287% +$50.8K ﹤0.01% 813
2025
Q3 		$14.2K Buy
1,802
+35
+2% +$249 ﹤0.01% 1094
2025
Q2 		$10.1K Buy
1,767
+594
+51% +$3.83K ﹤0.01% 1005
2025
Q1 		$9.57K Buy
1,173
+487
+71% +$4.51K ﹤0.01% 899
2024
Q4 		$6.46K Buy
686
+408
+147% +$4.24K ﹤0.01% 826
2024
Q3 		$2.97K Sell
278
-2,995
-92% -$32.6K ﹤0.01% 839
2024
Q2 		$32.5K Buy
+3,273
New +$33.6K ﹤0.01% 595

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Optiver Holding's FOLD Position: Q1 2026 in Review

Optiver Holding increased its Amicus Therapeutics (FOLD) stake by 10% in Q1 2026, buying an estimated $10.5K and bringing the position to 7,707 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

Optiver Holding first reported a position in FOLD in Q2 2024 and has held it in 8 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Optiver Holding held 7,707 shares of Amicus Therapeutics worth $111K as of Q1 2026.
  • Optiver Holding bought 731 Amicus Therapeutics shares in Q1 2026, an estimated $10.5K.
  • Amicus Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #882 holding.
  • Optiver Holding first reported a position in Amicus Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.